February 12, 2016 / 10:12 AM / 2 years ago

India's largest drugmaker Sun Pharma's Q3 profit beats estimates

MUMBAI, Feb 12 (Reuters) - India’s largest drugmaker, Sun Pharmaceutical Industries Ltd, reported a third-quarter net profit outpacing analysts’ estimates, lifting its shares up as much as 6.5 percent.

The world’s fifth-largest generic drugmaker’s net earnings for the quarter ended Dec. 31 were 14.17 billion rupees ($207.52 million), compared with 14.25 billion rupees a year earlier.

Analysts, on average, expected a net profit of 13.16 billion rupees. ($1 = 68.2350 Indian rupees) (Reporting by Zeba Siddiqui in Mumbai; Editing by Biju Dwarakanath)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below